Power Fatigue Syndrome Therapeutics Market Dimension to Develop by USD 51.84 million, Rising Use of Off-label Pharmacological Therapy for CFS to Increase Market Development

NEW YORK, Aug. 3, 2022 /PRNewswire/ — The “Power Fatigue Syndrome Therapeutics Market by Product (Ache relievers and NSAIDs, Antidepressant and antipsychotic medication, and Antimicrobial and immunomodulatory medication) and Geography (North America, Europe, Asia, and Remainder of World (ROW)) – Forecast and Evaluation 2022-2026″ report has been added to Technavio’s providing. The potential progress distinction for the power fatigue syndrome therapeutics market measurement between 2021 and 2026 is USD 51.84  million. To get the precise CAGR and the Y-O-Y progress fee, Request a Pattern Report

Technavio has announced its latest market research report titled Chronic Fatigue Syndrome Therapeutics Market by Product and Geography - Forecast and Analysis 2022-2026

Technavio has introduced its newest market analysis report titled Power Fatigue Syndrome Therapeutics Market by Product and Geography – Forecast and Evaluation 2022-2026

Key Market Dynamics:

  • Market Driver: The rising use of off-label pharmacological remedy for CFS is driving the expansion of the market. Graded train and CBT are thought-about the first-line remedy for CFS. Sufferers with CFS usually tend to seek the advice of a complementary or different healthcare supplier as an alternative of a physiotherapist or psychologist for recommendation and assist. As there are not any permitted medication for the remedy of CFS, a variety of ache relievers, antidepressants, antibiotics, and immunomodulators are being prescribed off-label for enhancing signs.

  • Market Problem: The affirmation of particular diagnostic exams for affirmation of CFS is difficult the expansion of the market. CFS could be a symptom of different medical circumstances, equivalent to power mononucleosis, fibromyalgia, neurological circumstances, Lyme illness, and sensitivity to sure chemical compounds. It may also be a symptom in lots of treatable ailments equivalent to despair, most cancers, subacute or power infections, psychosomatic ailments, and malingering. Thus, extra training is required about CFS amongst healthcare professionals. Such elements might problem the market progress within the forecast years.

Technavio supplies drivers, developments, and challenges that can affect the way forward for the market. View a Pattern Report

Market Segmentation

North America would be the main area with 42% of the market’s progress in the course of the forecast interval. The expansion is attributed to elements equivalent to excessive per capita pharmaceutical expenditure, entry to superior healthcare, the sturdy market presence of main distributors, and the rising consciousness about CFS. Furthermore, market progress on this area can be sooner than the expansion of the market in different areas. The US and Canada are the important thing nations for the power fatigue syndrome therapeutics market in North America. The rising prevalence of CFS within the US can be driving the expansion of the regional market. Based on the Facilities for Illness Management (CDC), the prevalence of CFS within the US is round 11.5%.

The ache relievers and NSAIDs section may have important market share progress in the course of the forecast interval. Ache relievers are probably the most generally used medication, as they may also help in relieving ache and lowering irritation. Ibuprofen is probably the most generally used NSAID. Physique ache is probably the most continuously reported cause for using NSAIDs in CFS sufferers. Arthritis and headache are the second-most and the third-most continuously reported causes, respectively.

Be taught concerning the contribution of every section summarized in concise infographics and thorough descriptions. View a Pattern Report

Some Firms Talked about

  • AIM ImmunoTech Inc.

  • Apotex Inc.

  • Aurobindo Pharma Ltd.

  • Bionpharma Inc.

  • Cadila Prescribed drugs Ltd.

  • Hikma Prescribed drugs Plc

  • Lupin Ltd.

  • Pfizer Inc.

  • Solar Pharmaceutical Industries Ltd.

  • Teva Pharmaceutical Industries Ltd.

  • Viatris Inc.

Need your report custom-made? Communicate to an analyst and personalize your report in line with your wants.

Associated Experiences

Narcolepsy Medication Market by Kind and Geography – Forecast and Evaluation 2022-2026

Psychological Well being Market by Service and Geography – Forecast and Evaluation 2022-2026

Power Fatigue Syndrome Therapeutics Market Scope

Report Protection


Web page quantity


Base yr


Forecast interval


Development momentum & CAGR

Speed up at a CAGR of 4.31%

Market progress 2022-2026

USD 51.84 million

Market construction


YoY progress (%)


Regional evaluation

North America, Europe, Asia, and Remainder of World (ROW)

Performing market contribution

North America at 42%

Key client nations

US, Canada, Germany, UK, France, US, Canada, Germany, UK, and France

Aggressive panorama

Main firms, aggressive methods, client engagement scope

Firms profiled

AIM ImmunoTech Inc., Apotex Inc., Aurobindo Pharma Ltd., Bionpharma Inc., Cadila Prescribed drugs Ltd., Hikma Prescribed drugs Plc, Lupin Ltd., Pfizer Inc., Solar Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.

Market Dynamics

Father or mother market evaluation, market progress inducers and obstacles, fast-growing and slow-growing section evaluation, COVID-19 affect and future client dynamics, and market situation evaluation for the forecast interval.

Customization purview

If our report has not included the information that you’re on the lookout for, you possibly can attain out to our analysts and get segments custom-made.

Browse Well being Care Market Analysis Experiences

Key Subjects Coated:

1 Government Abstract

2 Market Panorama

3 Market Sizing

4 5 Forces Evaluation

5 Market Segmentation by Product

6 Buyer Panorama

7 Geographic Panorama

8 Drivers, Challenges, and Traits

9 Vendor Panorama

10 Vendor Evaluation

11 Appendix

About Us

Technavio is a number one international expertise analysis and advisory firm. Their analysis and evaluation deal with rising market developments and supply actionable insights to assist companies determine market alternatives and develop efficient methods to optimize their market positions.

With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 experiences and counting, protecting 800 applied sciences, spanning throughout 50 nations. Their consumer base consists of enterprises of all sizes, together with greater than 100 Fortune 500 firms. This rising consumer base depends on Technavio’s complete protection, in depth analysis, and actionable market insights to determine alternatives in current and potential markets and assess their aggressive positions inside altering market eventualities.

Technavio Analysis
Jesse Maida
Media & Advertising and marketing Government
US: +1 844 364 1100
UK: +44 203 893 3200
E mail:media@technavio.com
Web site: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)



View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/chronic-fatigue-syndrome-therapeutics-market-size-to-grow-by-usd-51-84-million-increasing-use-of-off-label-pharmacological-treatment-for-cfs-to-boost-market-growth—technavio-301597588.html

SOURCE Technavio


Leave a Reply

Your email address will not be published. Required fields are marked *